C1 Esterase Inhibitor and Functional Complement Assays
ACCREDITATION STATUS:
UKAS accredited proficiency testing provider No. 7795
CLINICAL APPLICATION:
Diagnosis of Hereditary Angioedema and monitoring of complement activation
PURPOSE OF PROGRAMME:
Immunochemistry EQA scheme
ANALYTES:
Analyte | Default Unit |
---|---|
C1 Esterase Inhibitor | g/L |
Laboratories are required to return data on Complement C3 and C4 to permit the interpretation of the C1 EsteraseInhibitor levels
MATERIAL PROVIDED: Liquid format. Normal and pathological human serum Additional materials may be produced by the addition of purified C1 Esterase Inhibitor, C3 or C4 to an analyte free serum matrix
DISTRIBUTIONS PER YEAR: 4
SAMPLES PER DISTRIBUTION: 2
FREQUENCY OF DISTRIBUTION: Every three months as outlined in the Distribution Schedule
PROGRAMME OF ANALYSIS:
Data entry is via the web for the submission of results. Data analysis is commenced 28 days after sample dispatch. Late returns are accepted and will contribute to the laboratory's cumulative performance statistics
DATA ANALYSIS:
All Laboratory Trimmed Mean (ALTM) with truncation at 2SD, SD, and CV%. Reports also show method and manufacturer specific statistics. Individual laboratory performance is expressed in terms of MRBIS, SDBIS, and MRVIS. The Designated Value (DV) for calculation of VI is the Method Laboratory Trimmed Mean (MLTM) Chosen Coefficient of Variation is 10%
PERFORMANCE SCORING:
MRVIS
PERFORMANCE MONITORING:
Laboratory performance for the qualitative element of the Scheme is assessed over a running analytical window of 4 Distributions (12 months) Individual laboratory performance over a running analytical window of 4 Distributions (12 months) quantitation is expressed in terms of MRBIS, SDBIS and MRVIS
PERSISTENT POOR PERFORMANCE:
Defined as being in the Poor Performance category for two or more successive Distributions
Immunology, Immunochemistry & Allergy (IIA)
The External Quality Assessment Scheme for Immunology, Immunochemistry & Allergy (IIA) was founded in 1982 by Dr Anthony Milford Ward at Northern General Hospital, Sheffield. In 1982 the Service became known as the UK National External Quality Assessment Service for Immunology, Immunochemistry & Allergy. UK NEQAS IIA is part of the Sheffield Teaching Hospitals NHS Foundation Trust. For the most up-to-date scheme information (including any pilot schemes) please contact the centre directly.
Contact Details
- UK NEQAS Immunology, Immunochemistry & Allergy
- Sheffield Teaching Hospitals NHS Foundation Trust
- PO Box 894
- Sheffield
- S5 7YT
Immunology, Immunochemistry & Allergy (IIA)
- Telephone: +44 (0) 114 271 5715
- Email: ukneqas@immqas.org.uk
- Web: https://www.immqas.org.uk/